Article
B7H3 Targeting Gold Nanocage pH-Sensitive Conjugates for Precise and Synergistic Chemo-Photothermal Therapy against NSCLC
2023-06-06
Abstract excerpt
<h4>Background: </h4> The strategy of combining a drug delivery with an immune checkpoint target has been widely investigated in cancer therapy, but the remarkable benefit to patients from this strategy is still limited. B7 homolog 3 protein (B7-H3), also known as CD276 (B7-H3/CD276), is a promising anti-cancer therapeutic target that is broadly overexpressed on the surface of malignant cells and tumor vasculature...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9bc5a60a-a7e0-5845-ae5d-c409a983d58e
- DOI
- 10.21203/rs.3.rs-3000523/v1
